Table of Content

1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Generic Oncology Drugs Market Size
1.3 Market Segmentation
1.4 Global Macroeconomic Analysis
1.5 SWOT Analysis

2. Market Dynamics
2.1 Market Drivers
2.2 Market Constraints and Challenges
2.3 Emerging Market Trends
2.4 Impact of COVID-19
2.4.1 Short-term Impact
2.4.2 Long-term Impact

3 Associated Industry Assessment
3.1 Supply Chain Analysis
3.2 Industry Active Participants
3.2.1 Suppliers of Raw Materials
3.2.2 Key Distributors/Retailers
3.3 Alternative Analysis
3.4 The Impact of Covid-19 From the Perspective of Industry Chain

4 Market Competitive Landscape
4.1 Industry Leading Players
4.2 Industry News
4.2.1 Key Product Launch News
4.2.2 M&A and Expansion Plans

5 Analysis of Leading Companies
5.1 Pfizer Inc.
5.1.1 Pfizer Inc. Company Profile
5.1.2 Pfizer Inc. Business Overview
5.1.3 Pfizer Inc. Generic Oncology Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.1.4 Pfizer Inc. Generic Oncology Drugs Products Introduction
5.2 Mylan N.V.
5.2.1 Mylan N.V. Company Profile
5.2.2 Mylan N.V. Business Overview
5.2.3 Mylan N.V. Generic Oncology Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.2.4 Mylan N.V. Generic Oncology Drugs Products Introduction
5.3 NATCO Pharma Limited
5.3.1 NATCO Pharma Limited Company Profile
5.3.2 NATCO Pharma Limited Business Overview
5.3.3 NATCO Pharma Limited Generic Oncology Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.3.4 NATCO Pharma Limited Generic Oncology Drugs Products Introduction
5.4 Aurobindo Pharma.
5.4.1 Aurobindo Pharma. Company Profile
5.4.2 Aurobindo Pharma. Business Overview
5.4.3 Aurobindo Pharma. Generic Oncology Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.4.4 Aurobindo Pharma. Generic Oncology Drugs Products Introduction
5.5 GlaxoSmithKline plc
5.5.1 GlaxoSmithKline plc Company Profile
5.5.2 GlaxoSmithKline plc Business Overview
5.5.3 GlaxoSmithKline plc Generic Oncology Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.5.4 GlaxoSmithKline plc Generic Oncology Drugs Products Introduction
5.6 Lupin Pharmaceuticals
5.6.1 Lupin Pharmaceuticals Company Profile
5.6.2 Lupin Pharmaceuticals Business Overview
5.6.3 Lupin Pharmaceuticals Generic Oncology Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.6.4 Lupin Pharmaceuticals Generic Oncology Drugs Products Introduction
5.7 Sun Pharmaceutical Industries Ltd.
5.7.1 Sun Pharmaceutical Industries Ltd. Company Profile
5.7.2 Sun Pharmaceutical Industries Ltd. Business Overview
5.7.3 Sun Pharmaceutical Industries Ltd. Generic Oncology Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.7.4 Sun Pharmaceutical Industries Ltd. Generic Oncology Drugs Products Introduction
5.8 Merck & Company, Inc
5.8.1 Merck & Company, Inc Company Profile
5.8.2 Merck & Company, Inc Business Overview
5.8.3 Merck & Company, Inc Generic Oncology Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.8.4 Merck & Company, Inc Generic Oncology Drugs Products Introduction
5.9 Novartis AG
5.9.1 Novartis AG Company Profile
5.9.2 Novartis AG Business Overview
5.9.3 Novartis AG Generic Oncology Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.9.4 Novartis AG Generic Oncology Drugs Products Introduction
5.10 Celgene Corporation
5.10.1 Celgene Corporation Company Profile
5.10.2 Celgene Corporation Business Overview
5.10.3 Celgene Corporation Generic Oncology Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.10.4 Celgene Corporation Generic Oncology Drugs Products Introduction
5.11 Hikma Pharmaceuticals PLC
5.11.1 Hikma Pharmaceuticals PLC Company Profile
5.11.2 Hikma Pharmaceuticals PLC Business Overview
5.11.3 Hikma Pharmaceuticals PLC Generic Oncology Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.11.4 Hikma Pharmaceuticals PLC Generic Oncology Drugs Products Introduction
5.12 F. Hoffmann-La Roche Ltd
5.12.1 F. Hoffmann-La Roche Ltd Company Profile
5.12.2 F. Hoffmann-La Roche Ltd Business Overview
5.12.3 F. Hoffmann-La Roche Ltd Generic Oncology Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.12.4 F. Hoffmann-La Roche Ltd Generic Oncology Drugs Products Introduction
5.13 Teva Pharmaceutical Industries Ltd.
5.13.1 Teva Pharmaceutical Industries Ltd. Company Profile
5.13.2 Teva Pharmaceutical Industries Ltd. Business Overview
5.13.3 Teva Pharmaceutical Industries Ltd. Generic Oncology Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.13.4 Teva Pharmaceutical Industries Ltd. Generic Oncology Drugs Products Introduction

6 Market Analysis and Forecast, By Product Types
6.1 Global Generic Oncology Drugs Sales, Revenue and Market Share by Types (2015-2020)
6.1.1 Global Generic Oncology Drugs Sales and Market Share by Types (2015-2020)
6.1.2 Global Generic Oncology Drugs Revenue and Market Share by Types (2015-2020)
6.1.3 Global Generic Oncology Drugs Price by Types (2015-2020)
6.2 Global Generic Oncology Drugs Market Forecast by Types (2020-2025)
6.2.1 Global Generic Oncology Drugs Market Forecast Sales and Market Share by Types (2020-2025)
6.2.2 Global Generic Oncology Drugs Market Forecast Revenue and Market Share by Types (2020-2025)
6.3 Global Generic Oncology Drugs Sales, Price and Growth Rate by Types (2015-2020)
6.3.1 Global Generic Oncology Drugs Sales, Price and Growth Rate of Oral
6.3.2 Global Generic Oncology Drugs Sales, Price and Growth Rate of Parenteral
6.4 Global Generic Oncology Drugs Market Revenue and Sales Forecast, by Types (2020-2025)
6.4.1 Oral Market Revenue and Sales Forecast (2020-2025)
6.4.2 Parenteral Market Revenue and Sales Forecast (2020-2025)

7 Market Analysis and Forecast, By Applications
7.1 Global Generic Oncology Drugs Sales, Revenue and Market Share by Applications (2015-2020)
7.1.1 Global Generic Oncology Drugs Sales and Market Share by Applications (2015-2020)
7.1.2 Global Generic Oncology Drugs Revenue and Market Share by Applications (2015-2020)
7.2 Global Generic Oncology Drugs Market Forecast by Applications (2020-2025)
7.2.1 Global Generic Oncology Drugs Market Forecast Sales and Market Share by Applications (2020-2025)
7.2.2 Global Generic Oncology Drugs Market Forecast Revenue and Market Share by Applications (2020-2025)
7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
7.3.1 Global Generic Oncology Drugs Revenue, Sales and Growth Rate of Hospital pharmacy (2015-2020)
7.3.2 Global Generic Oncology Drugs Revenue, Sales and Growth Rate of Retail pharmacy (2015-2020)
7.3.3 Global Generic Oncology Drugs Revenue, Sales and Growth Rate of Online pharmacy (2015-2020)
7.4 Global Generic Oncology Drugs Market Revenue and Sales Forecast, by Applications (2020-2025)
7.4.1 Hospital pharmacy Market Revenue and Sales Forecast (2020-2025)
7.4.2 Retail pharmacy Market Revenue and Sales Forecast (2020-2025)
7.4.3 Online pharmacy Market Revenue and Sales Forecast (2020-2025)

8 Market Analysis and Forecast, By Regions
8.1 Global Generic Oncology Drugs Sales by Regions (2015-2020)
8.2 Global Generic Oncology Drugs Market Revenue by Regions (2015-2020)
8.3 Global Generic Oncology Drugs Market Forecast by Regions (2020-2025)

9 North America Generic Oncology Drugs Market Analysis
9.1 Market Overview and Prospect Analysis
9.2 North America Generic Oncology Drugs Market Sales and Growth Rate (2015-2020)
9.3 North America Generic Oncology Drugs Market Revenue and Growth Rate (2015-2020)
9.4 North America Generic Oncology Drugs Market Forecast
9.5 The Influence of COVID-19 on North America Market
9.6 North America Generic Oncology Drugs Market Analysis by Country
9.6.1 U.S. Generic Oncology Drugs Sales and Growth Rate
9.6.2 Canada Generic Oncology Drugs Sales and Growth Rate
9.6.3 Mexico Generic Oncology Drugs Sales and Growth Rate

10 Europe Generic Oncology Drugs Market Analysis
10.1 Market Overview and Prospect Analysis
10.2 Europe Generic Oncology Drugs Market Sales and Growth Rate (2015-2020)
10.3 Europe Generic Oncology Drugs Market Revenue and Growth Rate (2015-2020)
10.4 Europe Generic Oncology Drugs Market Forecast
10.5 The Influence of COVID-19 on Europe Market
10.6 Europe Generic Oncology Drugs Market Analysis by Country
10.6.1 Germany Generic Oncology Drugs Sales and Growth Rate
10.6.2 United Kingdom Generic Oncology Drugs Sales and Growth Rate
10.6.3 France Generic Oncology Drugs Sales and Growth Rate
10.6.4 Italy Generic Oncology Drugs Sales and Growth Rate
10.6.5 Spain Generic Oncology Drugs Sales and Growth Rate
10.6.6 Russia Generic Oncology Drugs Sales and Growth Rate

11 Asia-Pacific Generic Oncology Drugs Market Analysis
11.1 Market Overview and Prospect Analysis
11.2 Asia-Pacific Generic Oncology Drugs Market Sales and Growth Rate (2015-2020)
11.3 Asia-Pacific Generic Oncology Drugs Market Revenue and Growth Rate (2015-2020)
11.4 Asia-Pacific Generic Oncology Drugs Market Forecast
11.5 The Influence of COVID-19 on Asia Pacific Market
11.6 Asia-Pacific Generic Oncology Drugs Market Analysis by Country
11.6.1 China Generic Oncology Drugs Sales and Growth Rate
11.6.2 Japan Generic Oncology Drugs Sales and Growth Rate
11.6.3 South Korea Generic Oncology Drugs Sales and Growth Rate
11.6.4 Australia Generic Oncology Drugs Sales and Growth Rate
11.6.5 India Generic Oncology Drugs Sales and Growth Rate

12 South America Generic Oncology Drugs Market Analysis
12.1 Market Overview and Prospect Analysis
12.2 South America Generic Oncology Drugs Market Sales and Growth Rate (2015-2020)
12.3 South America Generic Oncology Drugs Market Revenue and Growth Rate (2015-2020)
12.4 South America Generic Oncology Drugs Market Forecast
12.5 The Influence of COVID-19 on South America Market
12.6 South America Generic Oncology Drugs Market Analysis by Country
12.6.1 Brazil Generic Oncology Drugs Sales and Growth Rate
12.6.2 Argentina Generic Oncology Drugs Sales and Growth Rate
12.6.3 Columbia Generic Oncology Drugs Sales and Growth Rate

13 Middle East and Africa Generic Oncology Drugs Market Analysis
13.1 Market Overview and Prospect Analysis
13.2 Middle East and Africa Generic Oncology Drugs Market Sales and Growth Rate (2015-2020)
13.3 Middle East and Africa Generic Oncology Drugs Market Revenue and Growth Rate (2015-2020)
13.4 Middle East and Africa Generic Oncology Drugs Market Forecast
13.5 The Influence of COVID-19 on Middle East and Africa Market
13.6 Middle East and Africa Generic Oncology Drugs Market Analysis by Country
13.6.1 UAE Generic Oncology Drugs Sales and Growth Rate
13.6.2 Egypt Generic Oncology Drugs Sales and Growth Rate
13.6.3 South Africa Generic Oncology Drugs Sales and Growth Rate

14 Conclusions and Recommendations
14.1 Key Market Findings and Prospects
14.2 Advice for Investors

15 Appendix
15.1 Methodology
15.2 Research Data Source